Do we have a "game changer" in treating patients with brain metastasis from renal cell carcinoma?
作者信息
Vornicova Olga, Bar-Sela Gil
机构信息
Cancer Center, Emek Medical Center, Afula, Israel.
Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S360. doi: 10.21037/atm.2019.09.50.
Abstract
摘要
相似文献
1
Do we have a "game changer" in treating patients with brain metastasis from renal cell carcinoma?
Ann Transl Med. 2019 Dec;7(Suppl 8):S360. doi: 10.21037/atm.2019.09.50.
2
Waking rest: a game changer or a name changer?
Sleep. 2019 Oct 9;42(10). doi: 10.1093/sleep/zsz172.
3
Gemcitabine: a game changer in nasopharyngeal carcinoma.
Lancet. 2016 Oct 15;388(10054):1853-1854. doi: 10.1016/S0140-6736(16)31394-0. Epub 2016 Aug 23.
4
Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: a potential game changer toward global standardization of care.
Hepatobiliary Surg Nutr. 2017 Jun;6(3):203-204. doi: 10.21037/hbsn.2017.04.02.
5
Immunotherapy in Squamous Cell Skin Carcinoma: A Game Changer?
Am J Med. 2017 May;130(5):e207-e208. doi: 10.1016/j.amjmed.2016.12.020. Epub 2017 Feb 27.
6
EHR game changer goal: rural hospital connectivity.
Health Data Manag. 2012 Mar;20(3):50.
7
Stop TRPC5 in Kidney Disease: A Game Changer for Renal Allograft Protection?
Transplantation. 2018 Jul;102(7):1027-1029. doi: 10.1097/TP.0000000000002209.
8
Aerogenous metastases: a potential game changer in the diagnosis and management of primary lung adenocarcinoma.
AJR Am J Roentgenol. 2014 Dec;203(6):W570-82. doi: 10.2214/AJR.13.12088.
9
Immune checkpoint inhibitors: a game changer for metastatic non-small-cell lung cancer.
Lancet Oncol. 2019 Oct;20(10):1334-1335. doi: 10.1016/S1470-2045(19)30508-X. Epub 2019 Aug 14.
10
High Endothelial Venules and Pancreatic Ductal Adenocarcinoma: A potential game changer.
EBioMedicine. 2019 Jan;39:29-30. doi: 10.1016/j.ebiom.2018.11.061. Epub 2018 Dec 5.
引用本文的文献
1
Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma.
Biomedicines. 2024 May 16;12(5):1111. doi: 10.3390/biomedicines12051111.
2
Fatal tumoral hemorrhage from brain metastases of renal cell carcinoma after stereotactic radiotherapy and immune checkpoint inhibitor and vascular endothelial growth factor-targeted therapy combinations.
IJU Case Rep. 2024 Mar 4;7(3):225-229. doi: 10.1002/iju5.12708. eCollection 2024 May.
3
Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience.
Diagnostics (Basel). 2024 Mar 5;14(5):553. doi: 10.3390/diagnostics14050553.
4
The Construction and Validation of a new Predictive Model for Overall Survival of Clear Cell Renal Cell Carcinoma Patients with Bone Metastasis Based on Machine Learning Algorithm.
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231165131. doi: 10.1177/15330338231165131.
5
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Cancer. 2022 Mar 1;128(5):966-974. doi: 10.1002/cncr.34016. Epub 2021 Nov 16.
6
Identification of a Risk Stratification Model to Predict Overall Survival and Surgical Benefit in Clear Cell Renal Cell Carcinoma With Distant Metastasis.
Front Oncol. 2021 Mar 11;11:630842. doi: 10.3389/fonc.2021.630842. eCollection 2021.
本文引用的文献
1
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
J Clin Oncol. 2019 Aug 10;37(23):2008-2016. doi: 10.1200/JCO.18.02218. Epub 2019 Jun 13.
2
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population.
Clin Genitourin Cancer. 2019 Aug;17(4):291-298. doi: 10.1016/j.clgc.2019.05.002. Epub 2019 May 13.
3
Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma.
Clin Genitourin Cancer. 2019 Apr;17(2):e273-e280. doi: 10.1016/j.clgc.2018.11.006. Epub 2018 Nov 22.
4
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
N Engl J Med. 2018 Aug 23;379(8):722-730. doi: 10.1056/NEJMoa1805453.
5
Surgery for brain metastases: An analysis of outcomes and factors affecting survival.
Clin Neurol Neurosurg. 2018 May;168:153-162. doi: 10.1016/j.clineuro.2018.03.011. Epub 2018 Mar 10.
6
Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
Clin Genitourin Cancer. 2017 Dec;15(6):717-723. doi: 10.1016/j.clgc.2017.05.010. Epub 2017 May 10.
7
Treatment of brain metastases of renal cell cancer with combined hypofractionated stereotactic radiotherapy and whole brain radiotherapy with hippocampal sparing.
Oncol Lett. 2016 Jun;11(6):3777-3781. doi: 10.3892/ol.2016.4440. Epub 2016 Apr 15.
8
Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection.
J Oncol. 2015;2015:636918. doi: 10.1155/2015/636918. Epub 2015 Nov 19.
9
A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastases.
Clin Genitourin Cancer. 2014 Feb;12(1):50-4. doi: 10.1016/j.clgc.2013.09.008. Epub 2013 Sep 28.
10
Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium.
Clin Genitourin Cancer. 2013 Sep;11(3):311-5. doi: 10.1016/j.clgc.2013.04.012. Epub 2013 May 15.
Zotero 插件